NCT05050201

Brief Summary

This study uses mixed methods to investigate the implementation of digital cognitive behavioural therapy for insomnia (Sleepio) in a first episode of psychosis service (FEP). Interviews will be conducted with keyworker clinicians and service users to consider their expectations for digital sleep intervention. The rates of recruitment into the study, eligibility, completion of baseline measures, completion of the intervention sessions, attrition from the intervention and completion of follow up measures will be recorded. Interviews will be conducted with keyworker clinicians and service users to consider their experiences of digital sleep intervention. The primary outcome will be a logic model describing factors acting upon the implementation of Sleepio in this population. The investigators will provide signal data in relation to changes in insomnia severity, psychosis symptomatology, and general mental health.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 20, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 5, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 20, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
Last Updated

September 20, 2021

Status Verified

September 1, 2021

Enrollment Period

1 year

First QC Date

August 5, 2021

Last Update Submit

September 17, 2021

Conditions

Keywords

insomniapsychosisfirst episode psychosisdigital CBTCBT-I

Outcome Measures

Primary Outcomes (5)

  • Implementation data - rates of consenting

    Rates of consenting and nonconsenting interested participants

    Across study timeline (8 months), across 10 weeks for Sleepio specific measures

  • Implementation data - eligibility

    Number of eligible vs. ineligible participants and reasons for ineligibility

    8 months

  • Implementation data - completion of measures

    Participant completion of measures assessment appointments and measures (ISI measure of insomnia severity, DASS-21 measure of mental wellbeing, R-GPTS measure of paranoia, SPEQ measure of hallucination, and Fear of Covid19). This outcome records whether or not these were completed by participants, whereas secondary outcomes 6-10 examine participant scores on these measures.

    8 months

  • Implementation data - completion of intervention sessions

    Measures attrition from intervention by recording how many sessions of intervention were completed by participant.

    Across 10 weeks per participant

  • Qualitative data

    Service user and clinician expectations and experiences of digital CBT-I intervention

    Across study timeline (8 months), across 12 weeks for service users (pre and post intervention)

Secondary Outcomes (5)

  • Insomnia severity

    10 weeks

  • Mental Wellbeing

    10 weeks

  • Paranoia symptomatology

    10 weeks

  • Hallucination symptomatology

    10 weeks

  • Anxiety regarding Covid19

    10 weeks

Study Arms (1)

Sleepio Intervention

EXPERIMENTAL

Participants using the Sleepio application - access for 6 sessions, over 10 weeks

Device: Sleepio

Interventions

SleepioDEVICE

Digital CBT application for insomnia

Sleepio Intervention

Eligibility Criteria

Age16 Years - 35 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Service users under the care of Esteem First Episode Psychosis Service in NHS GGC
  • Potentially affected by Insomnia Disorder (defined by Sleep Condition Indicator-02 score ≤2)
  • Who have access to a device they can use Sleepio on (a computer device with Safari or Google Chrome browser, or an iPhone device).

You may not qualify if:

  • Moderate to severe learning disability
  • Acute Psychosis (recent crisis contact or hospitalisation)
  • Incapacity to provide informed consent
  • Insufficient English to access intervention
  • Organic impairment
  • No access to a device which can be used for Sleepio intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Esteem North, NHS Greater Glasgow and Clyde

Glasgow, G213UW, United Kingdom

RECRUITING

Esteem South and Clyde, NHS Greater Glasgow and Clyde

Glasgow, G53 7TU, United Kingdom

RECRUITING

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersPsychotic Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental DisordersSchizophrenia Spectrum and Other Psychotic Disorders

Study Officials

  • Andrew Gumley

    NHS Greater Glasgow and Clyde; University of Glasgow

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Elaine O'Neill - Senior Research Administrator

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Participation is not masked - any service users who would like to participate may do so and their keyworker will be notified as a mandatory condition of consent
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: All service users who would like to trial the Sleepio intervention will be able to do so.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 5, 2021

First Posted

September 20, 2021

Study Start

April 20, 2021

Primary Completion

April 20, 2022

Study Completion

September 30, 2022

Last Updated

September 20, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations